OTC Pharmaceuticals in Norway

Introduction

OTC Pharmaceuticals in Norway industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Norway otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

• The over-the-counter (OTC) pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin and other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2010 annual average exchange rates.
• The Norwegian OTC pharmaceuticals market generated total revenues of $305.2 million in 2010, representing a compound annual growth rate (CAGR) of 4.3% for the period spanning 2006-2010.
• Analgesics sales proved the most lucrative for the Norwegian OTC pharmaceuticals market in 2010, generating total revenues of $64 million, equivalent to 21% of the market's overall value.
• The performance of the market is forecast to decelerate, with an anticipated CAGR of 3.4% for the five-year period 2010-2015, which is expected to lead the market to a value of $360.3 million by the end of 2015.

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in Norway

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in Norway

Leading company profiles reveal details of key otc pharmaceuticals market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Norway otc pharmaceuticals market with five year forecasts by both value and volume

Macroeconomic indicators provide insight into general trends within the Norway economy

Key Questions Answered

What was the size of the Norway otc pharmaceuticals market by value in 2010?

What will be the size of the Norway otc pharmaceuticals market in 2015?

What factors are affecting the strength of competition in the Norway otc pharmaceuticals market?

How has the market performed over the last five years?

Who are the top competitiors in Norway's otc pharmaceuticals market?